These models and simulations have been tagged “Screening”.
Based on Ransohoff DF, McNaughton Collins M, Fowler FJ. Why is prostate cancer screening so common when the evidence is so uncertain? A system without negative feedback. Am J Med. 2002;113:663-7. See IM-15991 for a generic Stock Flow Map
A generic stock and flow map of Cancer Screening and Treatment. See also IM-1525 for a specific Prostate PSA Map and Reference See IM-107014 for a more detailed prostate cancer specific map
Insight synthesis of exchanges to better understand the basis of this decision. Unstructured additions from GMcD